We have shown previously that the activity of lipoprotein lipase (LPL)
, the major enzyme responsible for hydrolysis of triglyceride containe
d in circulating lipoproteins, is associated with lipoproteins in post
heparin plasma. In other studies, microtiter plate assays showed that
LPL interaction with low density lipoprotein (LDL) and very low densit
y lipoprotein (VLDL) was decreased by antibodies to apolipoprotein (ap
o)B. To test whether antibodies to apoB affected LPL-LDL association i
n solution, two types of assays were performed, gel filtration and cop
recipitation. First we showed that LPL activity and immunoreactive mas
s co-eluted during gel filtration of normal postheparin plasma, approx
imately with the peak of low density lipoproteins. Then LPL was used f
or gel filtration studies in the presence and absence of LDL and anti-
apoB monoclonal antibodies. LPL association with LDL was diminished by
antibodies to the amino-terminal region of apoB; antibodies to the ca
rboxyl-terminal LDL receptor binding region of apoB were less effectiv
e. LDL binding to LPL containing heparin-agarose was also disrupted by
the amino-terminal antibodies to apoB. To determine the LPL-lipoprote
in association in situations in which the distribution of plasma lipop
roteins was altered, we studied plasma from two types of subjects with
dyslipidemias. The addition of I-125-labeled LPL to type 1 posthepari
n plasma produced two peaks of radioactivity, one peak eluted in the v
oid volume of the column (with the chylomicrons) and a second peak elu
ted just prior to the normal elution of low density lipoproteins. In p
ostheparin plasma from an abetalipoproteinemic subject, LPL eluted wit
h HDL. We conclude that LPL associates primarily with apoB-containing
lipoproteins. The reason for this appears to be that LPL interacts wit
h the apoB.